Novo Nordisk (NVO)

Candlestick chart with volume — data via Yahoo Finance · For educational use only

Dividends

Options Chain

• Slash Your Wegovy Costs: Novo Nordisk Reveals First-Ever Subscription Plan

  Novo Nordisk launches the first Wegovy subscription program. Save on injections and pills through Ro, WeightWatchers, LifeMD, and more.

  Benzinga·Mar 31, 2026positive

• LifeMD Launches Novo Nordisk Wegovy Subscription Program, Offering First Branded GLP-1 Telehealth Access With Up To $1,200 Annual Patient Savings

  LifeMD, Inc. (NASDAQ:LFMD), a leading provider of virtual primary care services, today announced the launch of Novo Nordisk's new Wegovy® (semaglutide) subscription program — the first and only GLP-1 subscription

  Benzinga·Mar 31, 2026positive

• WW International Says Eligible Weight Watchers Med+ Members Will Have Access To Subscription Pricing For Wegovy As A Result Of Expanded Collaboration Between Weight Watchers And Novo Nordisk

  WW International, Inc. (NASDAQ:WW) ("Weight Watchers"), the global leader in science-backed weight health, today announced that eligible Weight Watchers Med+ members will have access to subscription pricing for

  Benzinga·Mar 31, 2026positive

• Novo Nordisk Rolls Out New Multi-Month Subscription Program For Wegovy, Starting March 31

  Novo Nordisk today announced a new multi-month subscription program for Wegovy® (semaglutide) that provides eligible self-pay patients who enroll in the program through select telehealth providers a lower,

  Benzinga·Mar 31, 2026positive

• Novo Nordisk: Why I Still Find It An Interesting Opportunity

  Despite macro uncertainty and weakening obesity drug demand, Novo Nordisk trades at a multi-year low valuation. Read why NVO stock is a Buy.

  SeekingAlpha·Mar 30, 2026positive

Sentiment scored by an AI model on article tone. Not investment advice.